Carboplatin
FDA Approved: * October 14, 2004Pharm Company: * BEDFORD
Category: Cancer
Carboplatin, sold under the trade name Paraplatin among others, is a chemotherapy medication used to treat a number of forms of cancer.[1] This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma.[1] It is used by injection into a vein.[1] Side effects generally occur.[1] Common side effects include low blood cell levels, nausea, and electrolyte problems.[2][1 ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4239
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4244
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4246
Labeler:
Teva Parenteral Medicines, Inc.
Carboplatin 10 mg/ml Intravenous Injection, Solution
NDC: 0703-4248
Labeler:
Teva Parenteral Medicines, Inc.